GPCR antagonists (Theratechnologies)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGPCR antagonists (Theratechnologies)
Drug Alias NameEP4 GPCR antagonists (Theratechnologies)R-14 GPCR antagonists (Theratechnologies)FP GPCR antagonists (Theratechnologies)THG-1402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor antagonistsProstanoid EP4 receptor antagonists
TargetsProstanoid FP receptorProstanoid EP4 receptor
Therapy Area/IndicationsObstetric Labor, PrematureRenal InsufficiencyGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheratechnologies Inc
Active IndicationsN/A
Inactive IndicationsObstetric Labor, PrematureRenal InsufficiencyGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A